IH Convidecia as Second Booster Dose Against Breakthrough Infections
Clinical trial NCT05517642 · COMPLETED
Trial details
- NCT number
- NCT05517642
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2023-05-02
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.